The lesions evaluated in this study that can become cancerous are known as intraductal papillary mucinous neoplasms. (sciencedaily.com)
According to a new «proof of principle» study published in Aug. 27 issue of Cancer Prevention Research, Moffitt Cancer Center researchers hope to improve pancreatic cancer survival rates by identifying markers in the blood that can pinpoint patients with premalignant pancreatic lesions called intraductal papillary mucinous neoplasms (IPMNs). (sciencedaily.com)
Five patients (12.5 percent) required surgery (3 for pancreatic ductal adenocarcinoma and 2 for intraductal papillary mucinous neoplasia), the remaining 35 continue under surveillance. (sciencedaily.com)